Skip to main content

Oregon State Flag An official website of the State of Oregon »

Oregon.gov Homepage

Prescription Drug Affordability Board (PDAB)

Community forums in April, May

The Oregon Prescription Drug Affordability Board is hosting in person and online community forums in April and May to hear from patients, caregivers and others about the prescription drugs the board will review this year. Save the date for the events in Portland, Salem, Redmond, Beaverton and online.

  • Download a community forum flyer in English
  • Listen to a PDAB radio ad about the community forums

    • Click here to view the 2026 community forums

    Anyone needing American Sign Language interpretation for the community forums or other assistance due to a disability or language barrier can send an email or call 971-374-3724 at least 48 hours ahead of the meeting.


    Oregon PDAB is also inviting people to share their stories during the May 20 online board meeting. Sign up to speak by submitting the public comment form.

    Foros comunitarios en abril y mayo

    La Junta de Asequibilidad de Medicamentos Recetados de Oregon está organizando foros comunitarios en persona y en línea en abril y mayo. Estos foros son para escuchar a los pacientes, cuidadores de pacientes y otras personas acerca de los medicamentos recetados que la junta revisará este año. Guarde las fechas en su calendario para eventos en Portland, Salem, Redmond, Beaverton y en línea.

  • Descargue un volante del foro comunitario en español
  • Escucha un anuncio de radio de PDAB

    • The next PDAB meeting is:

    Wednesday, April 15, 2026
    9 A.M. Pacific Time

    Register here 

    Agenda

    Submit a feedback form about a prescription drug!

    About the PDAB

    The Oregon Prescription Drug Affordability Board is established in the Department of Consumer and Business Services under ORS 646A.693 to protect residents of Oregon, state and local governments, commercial health plans, health care providers, pharmacies licensed in Oregon and others within the health care system in this state from the high costs of prescription drugs. To learn more about the board’s work, see the FAQ page.